Shares of Recursion Pharmaceuticals (RXRX) spiked on Wednesday after the AI-driven drug developer significantly exceeded Street forecasts with its Q4 2025 financials, thanks primarily to a milestone ...

As sometimes-violent anti-ICE protests sweep the nation, the Democratic Socialists of America has created the “Red Rabbits Security Commission” to train members in “unarmed community defense.” While ...

The race for LA mayor has two candidates from the Democratic Socialists of America (DSA), including City Council member Nithya Raman. It is worth a look at the DSA’s political platform. The first item ...

Data Systems Analysts appointed John Foley to succeed Frances Pierce as chairman of the board and CEO. The transition, effective Feb. 1, coincides with several other executive appointments, the ...

A specter is haunting New York politics – the specter of the Democratic Socialists of America. Over the past 10 years, the socialist organization has had its ups and downs, but recently it has been on ...

Ricursive Intelligence, founded by two former Google researchers and valued at $4 billion, is among several efforts to automate the creation of artificial intelligence. Anna Goldie and Azalia ...

Recursive language models (RLMs) are an inference technique developed by researchers at MIT CSAIL that treat long prompts as an external environment to the model. Instead of forcing the entire prompt ...

Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with content, and download exclusive resources. Soroosh Khodami discusses why we aren't ready ...

New York City’s chapter of the Democratic Socialists of America (DSA) is organizing a large-scale effort to mobilize thousands of activists to respond to anticipated federal immigration enforcement ...

Recursion Pharmaceuticals (RXRX) added ~11% in the morning trading on Wednesday after J.P. Morgan upgraded the AI-driven biotech to Overweight from Neutral, citing a blockbuster sales potential for ...

Recursion Pharmaceuticals Inc (NASDAQ: RXRX) shares moved higher Wednesday after JPMorgan upgraded the stock to Overweight from Neutral and lifted its price target to $11 from $10. What Happened: ...